
Joseph Vento and Tian Zhang
Apr 11, 2025, 15:01
Joseph Vento: ASCO update on PARPi and ARPI therapy in BRCA-mut mHRPC with Tian Zhang
Joseph Vento, Oncologist at UT Southwestern Medical Center, posted on X:
“Our ASCO update on PARPi+ARPI therapy in BRCA-mut mHRPC
Why diff in combo vs seq crossover in BRCA way? Small n but fascinating results!
Ongoing PARPi combo trials in mHSPC including HARMONY led by Qian Janie Qin.”
Authors: Maha Hussain et al.
Arul M. Chinnaiyan
cancer
Channing J Paller
Daniel Shevrin
Emmanuel S Antonarakis
Jingsong Zhang
Joel Picus
Latifa A. Bazzi
Maha Hussain
Masha Kocherginsky
Matthew B. Rettig
Nabil Adra
Neeraj Agarwal
OncoDaily
Oncology
Robert Dreicer
Russell Z Szmulewitz
Ryan D. Stephenson
Scott T. Tagawa
Stephanie Daignault-Newton
Timothy M. Kuzel
Travis Gerke
Young E. Whang
Zachery R. Reichert
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 14, 2025, 09:15
Apr 14, 2025, 09:04
Apr 14, 2025, 09:03
Apr 14, 2025, 08:25